Search
for
Sort by
Research 571–600 of 687
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- Anti-Androgen Therapy in Female Adult Acne
- Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
- Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome
- The Value of Androgen Measures for Diagnosing Polycystic Ovary Syndrome (PCOS) in an Unselected Population
- The effect of vitamin D on the hormonal profile of women with polycystic ovarian syndrome: a systematic review and meta-analysis
- Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
- Anorexia nervosa and reproduction: connecting brain to gonads
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management
- Health-related quality of life and mental state in women with polycystic ovary syndrome and migration or minority background – A cross-sectional study
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- Polycystic Ovarian Syndrome
- Patient characteristics associated with symptoms of anxiety, depression, and reduced body appreciation in women with polycystic ovary syndrome
- Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome
- Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
- Iatrogenic cushing’s syndrome post intralesional triamcinolone acetonide in oral submucous fibrosis: 2 case reports
- Skin Androgen-Related Disorders: Hormonal Treatment
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
- An Indian Evidence-Based Study of Prevalence, Phenotypic Features, Lifestyle Modifications of Polycystic Ovarian Syndrome Patients